Q2 2018

Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001654954-18-009034

Q2 2018 · 10-Q

Revenue

$8.00K

−90.8% vs Q2 2017

Net Income

$3.42M

N/M vs Q2 2017

EPS Diluted

$1.24

N/M vs Q2 2017

Gross Profit$7,000+40.0%

Operating Income

Same quarter

Metric	Q2 2018	Q2 2017	Q2 2016	Q2 2015
Revenue	$8.00K	$87.00K	—	$10.00K
Net Income	$3.42M	-$1.07M	-$1.88M	-$1.71M
EPS Diluted	$1.24	-$0.59	-$52.95	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR